Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Merck & Co., Inc., Rahway, NJ, USA (United States) · DuPont (United States) · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
812
total citations
- FWCI
- 57.03
- Percentile
- 100%
- References
- 27
Citations per year
Authors
37- JWJun WangCorresponding
Merck & Co., Inc., Rahway, NJ, USA (United States)
- SSS.M. Soisson
Merck & Co., Inc., Rahway, NJ, USA (United States)
- KYKatherine Young
Merck & Co., Inc., Rahway, NJ, USA (United States)
- WLWesley L. Shoop
DuPont (United States), LEK Consulting (United States), Merck & Co., Inc., Rahway, NJ, USA (United States)
- SKSrinivas Kodali
Merck & Co., Inc., Rahway, NJ, USA (United States)
Topics & keywords
Topics
Keywords
- Antibiotics
- Enzyme
- Staphylococcus aureus
- Biochemistry
- Streptomyces
- Microbiology
- Antibacterial activity
- In vivo
No related works found for this paper.